| (USD) | Mar 2014 | Y/Y change |
|---|---|---|
| Revenue | 9.83M | — |
| Operating expense | — | — |
| Net income | 2.72M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, UTMD returned +19.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +29.1% |
| 1 year | +19.7% |
| 5 years | -11.1% |
| 10 years | +33.6% |
| All-time high | $111.56 (Nov 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in UTMD would be worth today ›Yes. Utah Medical Products, Inc. paid 4 dividends over the past 12 months. The most recent was $0.31 per share on Jun 17, 2026. The dividend yield is 1.73%.
Utah Medical Products, Inc. stock trades on NASDAQ under the ticker symbol UTMD.
Utah Medical Products, Inc. is part of the Healthcare sector.
Utah Medical Products, Inc. has a market cap of 227.80M USD, based on the latest quote.
Utah Medical Products, Inc. is expected to report earnings around Oct 22, 2026. That date is an estimate and has not been confirmed by the company.
Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, it offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, the company provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization products; LIBERTY, a urinary incontinence treatment and control system; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; BioPharm HP-PRT; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health center in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.
